Unique ID issued by UMIN | UMIN000012046 |
---|---|
Receipt number | R000014083 |
Scientific Title | Comparison of efficacy in pulmonary function of tiotropium / indacaterol and tiotropium / budesonide / formoterol in patients with COPD: Multicenter study. |
Date of disclosure of the study information | 2013/11/01 |
Last modified on | 2016/03/22 16:31:25 |
Comparison of efficacy in pulmonary function of tiotropium / indacaterol and tiotropium / budesonide / formoterol in patients with COPD: Multicenter study.
Comparison of efficacy of tiotropium / indacaterol and tiotropium / budesonide / formoterol in patients with COPD
Comparison of efficacy in pulmonary function of tiotropium / indacaterol and tiotropium / budesonide / formoterol in patients with COPD: Multicenter study.
Comparison of efficacy of tiotropium / indacaterol and tiotropium / budesonide / formoterol in patients with COPD
Japan |
Chronic obstructive pulmonary disease (COPD)
Pneumology |
Others
NO
To demonstrate the non-inferiority of efficacy of tiotropium / indacaterol versus tiotropium / budesonide / formoterol on pulmonary function in patients with moderate to severe COPD patients.
Efficacy
Confirmatory
Pragmatic
Not applicable
Improvement in FEV1 at 24 hours post dose (trough) before and after 8 weeks treatment.
Improvements in the data of spirometry and IOS at 24 hours post dose (trough) before and after 8 weeks treatment.
CAT score, transition dyspnea index (TDI), MMRC
Exacerbations.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
NO
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Medicine |
Add indacaterol on tiotropium treatment in COPD patients.
Add budesonide / formoterol on tiotropium treatment in COPD patients.
40 | years-old | <= |
Not applicable |
Male and Female
Smoking history of 10 pack-years or more
Diagnosis of moderate-to-severe COPD
Post bronchodilator FEV1 <80% predicted normal
Post-bronchodilator FEV1 / FVC <70%
Patients treated with tiotropium for more than 2 weeks
COPD with asthma
Patients who are already treated with ICS or oral corticosteroid regularly
Patients with a history of asthma
Patients who have experienced a COPD exacerbation within the previous 8 weeks.
Patients with uncontrolled cardiac diseases
90
1st name | |
Middle name | |
Last name | Masamichi Mineshita |
St. Marianna University School of Medicine
Division of Respiratory and Infectious Diseases
2-16-1 Sugao, Miyamae-ku, Kawasaki-City, Kanagawa
044-977-98111
m-mine@marianna-u.ac.jp
1st name | |
Middle name | |
Last name | Masamichi Mineshita |
St. Marianna University School of Medicine
Division of Respiratory and Infectious Diseases
2-16-1 Sugao, Miyamae-ku, Kawasaki-City, Kanagawa
044-977-98111
m-mine@marianna-u.ac.jp
Division of Respiratory and Infectious Diseases, St. Marianna University School of Medicine
none
Self funding
NO
神奈川県立循環器呼吸器病センター(神奈川県)、北里大学病院(神奈川県)、聖マリアンナ医科大学(神奈川県)、昭和大学藤ヶ丘病院(神奈川県)、昭和大学横浜市北部病院(神奈川県)、東海大学医学部内科系呼吸器内科学(神奈川県)、東海大学付属東京病院呼吸器循環器センター(東京都)、横浜市立大学附属市民総合医療センター(神奈川県)
2013 | Year | 11 | Month | 01 | Day |
Unpublished
Completed
2013 | Year | 10 | Month | 15 | Day |
2013 | Year | 11 | Month | 01 | Day |
2013 | Year | 10 | Month | 16 | Day |
2016 | Year | 03 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014083